To determine whether activation of the PI3K Akt pathway affects the sensitivity of breast cancer cells to chemotherapy, we added LY294002 and individual therapeutic agents to three cell lines that had low erbB2 levels but varied in basal Akt activity and measured apoptosis <a href=https://enhanceyourlife.mom/>priligy walmart</a>